PTC Therapeutics, Inc. (PTCT)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 25.16 |
| 開市 | 25.01 |
| 買盤 | 24.67 x 100 |
| 賣出價 | 31.47 x 100 |
| 今日波幅 | 24.47 - 25.26 |
| 52 週波幅 | 17.53 - 59.84 |
| 成交量 | |
| 平均成交量 | 857,612 |
| 市值 | 1.891B |
| Beta 值 (5 年，每月) | 0.67 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -8.37 |
| 業績公佈日 | 2024年4月25日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 27.91 |
ZacksPTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksBiotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.
ZacksPTC Therapeutics (PTCT) Up on Positive Regulatory Updates
PTC Therapeutics (PTCT) submits BLA for gene therapy Upstaza to the FDA and announces plans to resubmit its application for Translarna to the regulatory body. Its shares rise on these updates.
